Role of [ 18 F]FDG PET/CT in the management of G1 gastro-entero-pancreatic neuroendocrine tumors.

Ludovica MagiDaniela ProsperiGiuseppe LambertiMatteo MarascoValentina AmbrosiniMaria RinzivilloDavide CampanaGuido GentiloniBruno AnnibaleAlberto SignoreFrancesco Panzuto

Published in: Endocrine (2022)

F]FDG PET/CT in the diagnostic work-up of G1 GEP-NETs, which may be used in selected cases to detect those at higher risk for an unfavorable disease course.

Keyphrases

neuroendocrine tumors
breast cancer risk